Searchable abstracts of presentations at key conferences in endocrinology

ea0035p450 | Diabetes complications | ECE2014

Diabetic neuropathy in a young patient with recently diagnosed diabetes mellitus: an atypical presentation of insulin neuritis

Esteves Cesar , Neves Manuel Celestino , Lau Eva , Meneses Joana , Jorge Georgina , Carvalho Davide

Introduction: Insulin neuritis is a rare form of presentation of diabetic neuropathy, usually associated with the sudden intensification of glucose control in individuals with long standing uncontrolled diabetes mellitus.Objectives: To report a case of insulin neuritis in a young male, few weeks after diagnosis and insulin therapy initiation.Clinical case: Male, 22 years old, previous history of excess weight until he was 19 years ...

ea0035p1017 | Thyroid (non-cancer) | ECE2014

Adipokines and cardiovascular risk factors in patients with autoimmune thyroiditis and subclinical hypothyroidism

Neves Celestino , Esteves Cesar , Sokhatska Oksana , Palmares Carmo , Carvalho Davide , Delgado Luis , Medina Jose Luis

Aim: To evaluate the serum levels of resistin and adiponectin, and the potential relationship between these adipokines, thyroid function, lipid profile, C-reactive protein (CRP) and homocysteine levels in patients with autoimmune thyroiditis (AIT) and subclinical hypothyroidism (SCH).Methods: patients with AIT (58 females; 47.7±16.7 years) were studied; 33 of them had also SCH. These patients were diagnosed by a positive result in an anti-peroxidase...

ea0029p718 | Diabetes | ICEECE2012

Gender differences in metabolic outcomes of continuous subcutaneous insulin infusion therapy

Esteves C. , Neves M. , Belo S. , Pereira M. , Sousa Z. , Carvalho D.

Introduction: The continuous subcutaneous insulin infusion (CSII) is an alternative to multiple daily injection therapy in type 1 diabetes and its use is increasingly common due to the beneficial effects on the glycemic control of the patient.Aims: To find differences on outcomes of CSII therapy between genders. Patients and methods: Patients on CSII therapy in our department were included in the study and we recorded outcomes regarding the following set...

ea0029p873 | Endocrine tumours and neoplasia | ICEECE2012

Hypoglycemia by insulinoma: for the purposes of a case

Jorge G. , Nogueira C. , Esteves C. , Neves C. , Queiros J. , Oliveira M. , Pardal J. , Carvalho D.

Clinical caseIntroduction: Insulinoma is a rare disorder with an estimated incidence of 1 case per 250 000 people per year.Case report: 37 years old female, with a history of irritable bowel syndrome, dyslipidemia and kidney stones. In December 2010, she developed a headache, dizziness and visual disturbances, predominantly in the evening and amnesia for some of the episodes. Initially interpreted as peripheral vertiginous syndrome, because of recurrence...

ea0026p642 | Clinical case reports | ECE2011

Giant invasive macroprolactinoma

Alves M , Neves C , Pereira J , Bastos M Ayres , Bernardes I , Carvalho-Braga D , Carvalho D

Background: Apart from signs of hyperprolactinaemia, patients with macroadenomas with extrasellar extension generally seek medical attention due to mass effect. Macroprolactinomas, particularly in men, may occasionally exhibit a very aggressive clinical course.Case report: Male 37 years old that went to a Neurology consultation complaining of progressively more frequent self-limiting episodes of restraint, silence and time and space disorientation in the...

ea0026p643 | Clinical case reports | ECE2011

Bexarotene associated dyslipidaemia and central hypothyroidism in a patient with Sézary syndrome

Alves M , Neves C , Azevedo F , Correia O , Carvalho-Braga D , Carvalho D

Background: Sézary syndrome (SS) is a more aggressive leukemic variant of cutaneous T-cell lymphoma (CTCL). Bexarotene (Targretin) is a synthetic rexinoid analogue designed for the treatment of advanced stages of cutaneous manifestations of CTLC. Bexarotene selectively suppresses thyrotropin secretion and up to 40% of patients develop reversible idiopatic central hypothyroidism. Severe mixed dyslipidemia may be present in up to 70%.Case report: Seve...

ea0026p653 | Clinical case reports | ECE2011

Maltose interference in the determination of blood glucose levels by test strips based on glucose dehydrogenase-PQQ method: a case report

Belo S , Rodrigues P , Alves M , Neves C , Magalhaes A , Carvalho D

Background: The different systems for monitoring capillary blood glucose levels may suffer interference from various substances.Case report: Male patient, 48 years old, with history of hypertension, dyslipidemia and previous smoking. He presented also type 1 diabetes mellitus, with 37 years of progress, with diabetic retinopathy, kidney failure, in peritoneal dialysis since 2009, and ischemic heart disease (myocardial infarction in 2005). He was treated ...

ea0020p413 | Diabetes and Cardiovascular | ECE2009

Quality of life in diabetes mellitus: conditional issues of treatment and coping strategies

Pereira Miguel , Neves Celestino , Pereira Joao , Carqueja Eduardo , Alves Marta , Carvalho Davide , Coelho Rui , Medina Jose

Introduction: Quality of life (QoL) is a subject of increasing interest in the health context. Applied to a chronic condition like diabetes, this issue could give an overall perspective of the health outcome.Objective: To evaluate the coping mechanisms, the treatment issues and its contribution to QoL of diabetes patients.Patients and methods: We gathered a sample of 94 diabetic subjects, 50% males, 55.3% type 1, with a mean age of...

ea0056p607 | Obesity | ECE2018

Prevalence of obesity in a population of patients with HIV: relationship with clinical lipodistrophy, effect of sex, age, viral replication, duration of disease and cart

Guerreiro Vanessa , Neves Joao , Serrao Rosario , Sarmento Antonio , Carvalho David , Freitas Paula

Introduction: Adipose tissue disturbances (lipodystrophy and obesity) are prevalent in patients infected with HIV. Our aims were to evaluate the prevalence of obesity and the association with lipodystrophy, the effect of gender, age, viral replication, duration of disease and cART in a population of HIV patients under cART.Methods: In this retrospective study, 580 patients were included. The characteristics of the population are presented through percent...

ea0073aep228 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Association of IDO polymorphism with oxidative status, metabolic control and inflammation in patients with type 2 diabetes mellitus

Neves Marta , Bicho Manuel , Santos Ana Carolina , João F. Raposo , Valente Ana

IntroductionThe Indoleamine 2.3-dioxygenase (IDO) is an enzyme involved in tryptophan metabolism, encoded by the IDO1 gene in humans. In Caucasians, the rs9657182 polymorphism of IDO gene was found to be associated with neurobehavioral complications, especially depression. Several studies in Type 2 Diabetes Mellitus (T2DM) describe psychological factors as barriers to the successful implementation of a healthy eating plan. According to our knowledge ther...